Objectives. This study sought to evaluate changes in early morbidity and mortality as well as predictors of outcome in our must recent 339 patients undergoing modified Fontan operations.
One-year survival improved to 88% from 79%, and 5-year survival to 81% from 73% (p = 0.006). Patients with common atrioventricular valves and those who took daily preoperative diuretic medication or had either postoperative renal failure or elevated postbypass right atrial pressure were at increased risk for early mortality. Young age was not found to be a risk factor for early mortality. Early mortality for patients with heterotaxia decreased dramatically: recent 30-day mortality was 15% compared with 41% in the early heterotaxy cohort.
Conclusions. Many factors may have contributed to decreased early mortality after Fontan. Improved patient selection, younger age at time of operation, refinements in surgical techniques and postoperative management may all have had important roles. Proposed technical modifications of the Fontan operation must be evaluated in light of these improved results.
(JAm Coil Cardiol 1996; 28:480-6) In 1971, Fontan and colleagues (1) reported the first successful total right heart bypass that separated the pulmonary and systemic circulations and relieved ventricular volume overload in patients with tricuspid atresia. Recently, revised selection criteria have been suggested, and many technical modifications of the Fontan operation have been proposed (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Some of these modifications (4,5) involve a persistent interatrial communication ("fenestration") that allows an ongoing right-toleft shunt. Because these most recent modifications represent a major change in approach to these patients, it seemed that a reassessment of early postoperative results of the nonfenestrated Fontan operation was indicated. Therefore, we studied the clinical course and outcomes of a recent cohort of patients (n = 339) who had Fontan operations at the Mayo Clinic (operations performed from 1987 to 1992). This cohort was then compared to our previously reported results in patients who had Fontan operations before 1987 (n = 500). In addition, an attempt was made to identify factors that currently were predictive of early mortality.
Methods
Patients. Clinical data from outpatient records and hospital charts were reviewed for all 339 patients who had a Fontan operation at the Mayo Clinic between January 1, 1987, and December 31, 1992 ("recent cohort"). These results were compared with similar data obtained from the first 500 patients who had a Fontan operation at the Mayo Clinic between 1973 and 1986 (this group is referred to as the "early cohort") (3,6-10). These data were available in an existing computer-ized data base. None of the patients in either cohort had atrial fenestration at the time of the Fontan operation.
Measurements. Data from patient records, preoperative echocardiograms and cardiac catheterizations were reviewed to assess factors that have been described previously as possibly being predictive of early mortality after Fontan operation (a list of all variables analyzed appears in a footnote in the Results section). Arrhythmias were documented by surface electrocardiogram, Holter monitoring or rhythm strip tracings. Early mortality was defined as death occurring at any time before hospital discharge or within 30 days after operation (even if the patient had been discharged). The day of operation was considered day i for calculating the length of hospital stay, intubation and chest tube drainage. The duration of chest tube drainage was "prolonged" if it continued beyond 14 days. The hospital stay was "prolonged" after 21 days. Postoperative mean right atrial pressure was measured after the discontinuation of cardiopulmonary bypass but before sternal reapproximation. Renal failure was defined as the need for peritoneal dialysis or hemodialysis. Impaired hepatic function was defined as clinical jaundice associated with elevated serum transaminase levels.
Follow-up. Follow-up regarding vital status of hospital survivors was obtained by reviewing outpatient records, correspondence letters and vital status questionnaires. Survival beyond the last patient contact was not assumed.
Statistical analysis. All the factors described in previous Mayo Clinic publications (3, (6) (7) (8) (9) (10) as being predictive of early mortality were analyzed as possible predictors of outcome in the recent cohort. In addition, type of Fontan connection and pacemaker placement were also assessed as possible predictors of outcome. Univariate assessment of the association of variables with mortality was performed using chi-square and Wilcoxon rank-sum tests. Univariate comparisons of variables that differentiated the recent cohort from the early cohort were performed with the same tests. Cumulative actuarial survival was estimated using the Kaplan-Meier method (15) . For the multivariate assessment of factors potentially associated with early mortality, the preoperative and perioperative or postoperative variables used were those indicated to be univariately associated with early mortality. Multivariate analysis was performed using the logistic regression procedures available in the SAS statistical analysis system (16) . A stepwise, backward elimination of the nonsignificant variables was performed using a p value cut point to retain variables with p < 0.02. For all other comparisons, two-tail p values -<0.05 were taken as evidence of findings not attributable to chance. [16%] of 500, p = 0.002). Patients in the recent cohort were significantly younger (median 7 years, range 1 to 38) than those in the early cohort (median 10 years, range 1 to 42, p < 0.001). There were more patients with complex anatomy (not tricuspid atresia or double-inlet left ventricle) in the recent cohort than in the early group (60% vs. 36%, p < 0.001). The hemodynamic features of both cohorts were similar ( Table 2 ). The only statistically significant differences in hemodynamic values between the two cohorts were preoperative ventricular enddiastolic pressure and postoperative mean right atrial pressure. The early cohort had more patients in the high extreme of the range for these pressures, although the means and medians were similar.
Results

Patients
Univariate analysis of factors affecting early mortality in the recent cohort. Preoperative factors. Preoperative factors that were significantly associated with early mortality by univariate analysis are listed in Table 3 . Those factors included cardiothoracic ratio >0.60, ambiguous atrial situs, common atrium, common atrioventricular valve, total anomalous pulmonary venous connection and daily diuretic therapy.
Postoperative factors. Intraoperative and postoperative factors affecting early mortality by univariate analysis included atrioventricular valve repair or replacement, mean right atrial pressure (immediately postoperative) >20 mm Hg and the postoperative occurrence of any of the following: pericardiocentesis, supraventricular tachycardia, renal failure or impaired hepatic function (Table 3) . A "lateral tunnel"-type anastomosis was performed in 55% of patients (187 of 339) in *Significantly different, Wilcoxon rank sum test; statistical significance was achieved because the high extreme of the range for these variables was lower in the recent cohort, although the mean and median values in the early and recent cohorts were similar. Data presented are median (range) or mean value _+ SD. C/T = cardiothoracic ratio; EF = ejection fraction; PAP -pulmonary artery pressure; RAP -right atrial pressure; RPA = pulmonary arteriolar resistance; VEDP -ventricular end-diastolic pressure.
the recent cohort. This type of connection did not affect early mortality in either a positive or negative way, nor did prolonged hospitalization or prolonged chest tube drainage. Numerous other preoperative and postoperative factors were analyzed and were not found to significantly influence early mortality.* Multivariate analysis of factors affecting early mortality in recent cohort. Multivariate assessment was performed as outlined in Methods. Initial candidate predictors were all of the variables found to be associated with early death by univariate analysis (Table 3) . By use of logistic regression, a stepwise, * Preoperative factors analyzed were age, gender, primary cardiac lesion, cardiothoracic ratio >0.60, heterota~, previous surgical procedures, history of arrbytbmia, use of antiarrhythmic or diuretic medications, pulmonary artery distortion, nonconfluent pulmonary arteries, aortic/subaortic stenosis, pulmonary valve stenosis or atresia, cardiac position, ambiguous atrial situs, presence of common atrium, presence of common atrioventricular valve, total anomalous pulmonary venous connection, coronary artery anomalies, anomalies of systemic venous connection, partial anomalous pulmonary venous connection, ventricular morphology, pulmonary arteriolar resistance, ventricular end-diastolic pressure, ventricular ejection fraction, "Fontan index" (9) , coarctation (present or repaired), juxtaposed atrial appendages and atrioventricular or pulmonary valve closure.
Postoperative factors analyzed were type of Fontan connection, ventricular or supraventricular arrhythmias, complete heart block, cardiopulmonary bypass time, cross-clamp time, temporary atrial or ventricular pacing, permanent pacemaker placement, pulmonary artery confluence restoration, pulmonary artery angioplasty, mean right and left atrial pressure, systemic blood pressure, subaortic resection, chylous pleural effusion, reoperation for tracheotomy, stroke or seizure, hemidiaphragm paralysis, reoperation for bleeding, reoperation for right atrial thrombus, reoperation for thoracic duct ligation, pericardiocentesis, reoperation for atrial patch dehiscence, reoperation for conduit obstruction, antiarrhythmic medication use, tboracentesis, postoperative renal failure and postoperative impaired hepatic function.
Factors associated with early mortality are also listed in Table 3 .
backward elimination of the nonsignificant variables was performed. The p value cut point to retain variables was <0.02. This resulted in three variables being identified as multivariate risk factors for early death: postoperative renal failure (p < 0.001), postoperative right atrial pressure greater than 20 mm Hg (p = 0.008) and the presence of a common atrioventricular valve (p = 0.017). There were 230 patients with none of these three risk factors. Early mortality was 3% (7 of 230) in this group. Of 48 patients with common atrioventricular valve but normal renal function and right atrial pressure less than 20 mm Hg, there was no early mortality (0%). Twelve patients had right atrial pressure elevated above 20 mm Hg as a sole multivariate risk; there was one early death (8%) in this group. Twenty patients had renal failure alone, and there were five early deaths (25 %). Nineteen had renal failure and at least one of the two other variables present, and 14 (74%) of these patients died. Of five patients with a common atrioventricular valve and elevated right atrial pressure, there were two early deaths (40%). Presence of postoperative supraventricular tachycardia met the usual criteria of significance (p < 0.05), but in light of the number of variables considered, and because this factor was only marginally significant by univariate analysis (p = 0.044, Table 3 ), it was not included as a significant multivariate predictor.
In order to assess which preoperative factors were independently associated with early mortality, a separate multivariate analysis was performed. This analysis included only the "preoperative" factors (see Table 3 ) found to be significantly associated with early mortality by univariate analysis (i.e., information known to the clinician during the preoperative evaluation). Statistical methods used were identical to those used for the overall analysis described above. Two of the preoperative variables were found to be independently associated with an increased risk of early mortality. They were the presence of a common atrioventricular valve (p < 0.001) and daily diuretic therapy (p = 0.007). There were 225 patients who had neither of these risk factors, and early mortality in this group was 4.9% (11 of 225). Forty-five patients were on daily diuretic therapy but did not have common atrioventricular valves; early mortality in this group was 11.1% (5 of 45). Fifty-nine patients had common atrioventricular valves but were not on daily diuretic medication; early mortality in these patients was 15.3% (9 of 59). When both risk factors were present in the same patient, early mortality was 50% (5 of 10).
Influence of age on early mortality. In the recent cohort, 20% of patients (69 of 339) were under 4 years old, and early mortality in this subgroup was 13% (9 of 69); 34 (10%) of 339 patients were younger than 3 years old, and early mortality for these patients was 9% (3 of 34). This was a significant decrease in mortality for patients less than 4 years of age compared with the early cohort (14 [27%] of 51, p = 0.047) (10) . In the recent cohort, early mortality for patients <4 years old was not significantly different from early mortality for older patients (21 [8%] of 270).
In the recent cohort, 46 of 339 patients (14%) were adults *Atrial flutter, atrial fibrillation, atrial tachycardia or accelerated junctional rhythm. AV = atrioventricular; EM = early mortality; other abbreviations as in Table 2 .
(age ---18 years), and early mortality was 5 (11%) of 46. This rate was not significantly different when compared with either early mortality in recent younger patients (25 [9%] of 293) or with results from the early cohort (5 [6.5%] of 77). Patient age was not significantly associated with arrhythmias, length of hospitalization, duration of chest tube drainage or need for reoperation.
Heterotaxy. There were 62 patients with either asplenia or polysplenia in the recent cohort. Early mortality was 14.5% in this group. Atrioventricular valve regurgitation was significantly more common in heterotaxy patients than in nonheterotaxy patients (54 [87%] of 62 vs. 139 [50%] of 277, p < 0.001).
Also, need for atrioventricular valve repair or replacement during the Fontan operation was more common in heterotaxy than nonheterotaxy patients (45% vs. 14%, p < 0.001). In heterotaxy patients without concurrent atrioventricular valve repair or replacement, early mortality was not significantly different from the early mortality observed in nonheterotaxy patients (9% vs. 7%, p = 0.7). Postoperative supraventricular tachyarrhythmias (atrial flutter, atrial fibrillation, atrial tachycardia and accelerated junctional rhythm) were significantly more common in heterotaxy patients compared with nonheterotaxy patients (45% vs. 29%, p = 0.008).
Heterotaxy: comparison of early and recent cohorts. In the early cohort, 49 (10%) of 500 patients had a heterotaxy syndrome (23 asplenia, 26 polysplenia). In the recent cohort, the proportion of patients with heterotaxy syndromes increased to 18% (62 of 339) (34 asplenia, 28 polysplenia). In the recent heterotaxy group, early mortality decreased significantly to 14.5% (9 of 62) as compared to the early heterotaxy patients (21 [43%] of 49, p = 0.001). In the early cohort, asplenia carried a greater risk for early mortality than polysplenia (61% vs. 27%). In the recent cohort, there was no difference in early mortality between patients with asplenia (5 [15%] of 34) and polysplenia (4 [14%] of 28).
Arrhythmias. Tachyarrhythmias. Preoperatively, 46 (14%)
of 339 patients had a history of tachyarrhythmia. Preoperative history of tachyarrhythmia did not correlate with increased early mortality. During the postoperative hospitalization, 32% of patients (107 of 339) had postoperative supraventricular tachyarrhythmias (atrial flutter, atrial fibrillation, atrial tachycardia or accelerated junctional rhythm), and only 8% of patients (27 of 339) had a postoperative ventricular arrhythmia. In the multivariate analysis, postoperative supraventricular tachyarrhythmia was weakly correlated with increased risk of early mortality after Fontan operation (p = 0.033, Table 3 ). However, the degree of significance was considered to be borderline because of the number of variables considered and the variable selection process that was employed. Although 40% of patients in the recent cohort had transient postoperative tachyarrhytfimias, only 41 (13%) of 311 required an antiarrhythmic medication other than digoxin at the time of hospital discharge.
Bradyarrhythmias. In the recent cohort, complete heart block was present in ll (3%) of 339 patients before the Fontan operation. Complete heart block developed in an additional 12 (4%) of 328 patients during the Fontan hospitalization. Twenty-two percent of patients (73 of 339) required prolonged (>5 days) temporary pacing for sinus node dysfunction or junctional rhythm in order to maintain adequate cardiac output. A permanent pacemaker was placed or replaced in 17 patients (6%) during the Fontan hospitalization. Neither pace- maker placement nor prolonged temporary pacing was associated with increased early mortality. Hospital course. Median duration of hospitalization was 14 days (range 7 to 86). Median duration of intubation was 3 days (range 1 to 75). Median duration of chest tube drainage was 12 days (range 4 to 72). In 123 (36%) of 339 patients, chest tube drainage was prolonged (>14 days), and in 81 (24%) of 339 patients, the hospital period was prolonged (>21 days). Reoperation (including reexploration for bleeding) during the Fontan hospital period was necessary in 54 (16%) of 339 patients. The only reoperation that was significantly associated with early mortality was take-down of the Fontan connection (p = 0.001). Three of four patients (75%) in the recent cohort who had a take-down died.
Short-term follow-up. Follow-up information was available for 285 (92%) of 309 patients who survived to hospital discharge or for at least 30 days postoperatively. Mean duration of follow-up was 2.2 years (range 0.02 to 6.7). Overall, the 6-month actuarial survival estimate was 90%, 1-year survival was 88%, and 5-year survival was 81% for the recent cohort (Fig. 1) . The five-year survival estimate in the recent cohort was significantly (p = 0.006) improved compared with that for the early cohort. In the early series, 6-month survival was 81%, 1-year survival was 79%, and 5-year survival was 73% (Fig. 1) .
Short-term survival after Fontan operation for heterotaxy patients in the recent cohort improved significantly (p < 0.001) compared with survival of heterotaxy patients in the early cohort (6-month survival 84% vs. 57%; 1-year survival 78% vs. 53%; 5-year survival 73% vs. 42%) (Fig. 2) .
Short-term survival after Fontan operation for young patients (<4 years) in the recent cohort was significantly (p = 0.01) improved compared with the early cohort (6-month survival 82% vs. 65%; 1-year survival 82% vs. 63%; 5-year survival 82% vs. 59%) (Fig. 3) .
Discussion
Risk factor analysis. In 1977, Choussat and colleagues (11) described 10 criteria for selecting patients for the Fontan operation. Subsequent experience has shown that many of these criteria should be considered to be risk factors for but not absolute contraindications to the Fontan operation. Our recent experience demonstrated that patients with common atrioventricular valves, those requiring daily diuretic therapy and patients with specific postoperative problems (mean right atrial pressure >20 mm Hg or renal failure) were at significant risk for increased early mortality. No other factors were significantly predictive of early mortality in the multivariate analyses performed in this study. However, this does not imply that traditional preoperative risk factors (such as pulmonary artery hypoplasia, decreased ventricular ejection fraction, increased ventricular end-diastolic pressure, increased pulmonary artery pressure and increased pulmonary arteriolar resistance) are unimportant. In fact, they are likely to be at least as important as the risk factors identified in this study. Indeed, few patients with these previously defined "high risk" characteristics were selected for Fontan operation in the recent cohort.
Younger age at the time of Fontan operation may contribute to the improved survival observed in this study (17) . Young patients, specifically those under 4 years old, have been reported to experience increased early mortality after Fontan operation (10) . However, during the last 20 years, early mortality after Fontan for young patients has decreased pro- (18, 19) . However, the number of patients in the recent cohort who had previous cavopulmonary connections was small (24 unilateral, 6 bidirectional) and, thus, was not subject to meaningful statistical analysis. Heterotaxy and related syndromes. The Fontan operation is the preferred form of definitive palliation for patients with complex cyanotic heart disease associated with the heterotaxy syndromes. In the recent cohort, early mortality after Fontan for heterotaxy patients has decreased dramatically compared to the early cohort (14.5% vs. 43%). Many factors, including the use of an intraatrial conduit to route hepatic venous and inferior vena caval blood flow to the pulmonary arteries, may have contributed to these improved results. In the early cohort, patients with asplenia had increased early mortality compared with patients with polysplenia (61% vs. 27%). But in the recent cohort, early mortality after Fontan operation is similar in these two subsets of patients (asplenia, 15% vs. polysplenia, 14%).
Atrioventricular valve repair. Atrioventricular valve repair or replacement, a recognized risk factor for early mortality, was required more frequently in heterotaxy than nonheterotaxy patients (45% vs. 14%). If one controls for atrioventricular valve repair or replacement, then the outcomes observed in recent patients with heterotaxy are similar to those in patients without heterotaxy syndromes. Patients with heterotaxy syndromes who did not have atrioventricular valve procedures had early mortality of 9%, compared to 21% in heterotaxy patients who had atrioventricular valve procedures.
Nonfenestrated versus fenestrated approach. The length of the hospital stay (median 14 days) observed in the recent cohort is similar to that reported by medical centers that routinely perform atrial fenestration (4, (20) (21) (22) . However, no patient in the present series had an atrial fenestration performed. In the recent cohort, 36% of patients had chest tube drainage that was defined as prolonged (>14 days), and 24% of patients were hospitalized for longer than 21 days. It appears that centers that routinely perform fenestration have lower rates of prolonged chest tube drainage and fewer prolonged postoperative hospital stays (4, (20) (21) (22) . However, comparison of results from different centers is difficult for many reasons, including differences in surgical techniques and postoperative care and, most importantly, patient selection and heterogeneity. It is unclear whether the reduction in initial hospital stay and duration of chest tube drainage justifies the potential morbidity (including risk of paradoxic embolization and desaturation) from a persistent postoperative right-to-left shunt and the added economic cost of subsequent atrial baffle fenestration closure.
It seems that it would still be difficult to predict which patients would benefit from atrial baffle fenestration, as most patients have a satisfactory result without fenestration. In most instances, postoperative management can be successfully accomplished with hemodynamic adjustments, prevention of acidosis and pharmacologic manipulation of the pulmonary vasculature, including the potential benefits of inhaled nitric oxide. Perhaps for these reasons, atrial baffle fenestration is best reserved for patients who have right atrial pressures ->20 mm Hg after cessation of cardiopulmonary bypass and optimization of hemodynamic variables.
Short-term follow-up. Information regarding vital status was available for 92% of patients in the recent cohort. Although there is ongoing risk for late morbidity and mortality after Fontan operation, the short-term survival for recent Fontan patients has improved markedly. Current 1-year survival was 88%, and 5-year survival was 81%. By comparison, 1-year and 5-year survival in the early cohort was 79% and 73%, respectively. Also, short-term survival for heterotaxy patients, a recognized "high-risk" subgroup, has also improved dramatically (1-year survival 78%; 5-year survival 73%) compared with the early cohort (1-year survival 53%; 5-year survival 42%).
Conclusions. Early and short-term survival after the nonfenestrated Fontan operation have improved dramatically despite the increased anatomic complexity and younger age of the recent cohort of patients. In the recent cohort, early survival, even for traditionally high risk heterotaxy syndrome patients, has improved significantly. Also, young age (between 2 and 4 years of age) no longer increases operative risk for Fontan patients. Many factors may have contributed to the improvement in early and short-term survival that was observed. Because many of these changes were subtle and tended to evolve continuously, the factors most responsible for these improvements could not be specifically identified by retrospective statistical analysis. It is possible that improved patient selection, younger age at time of operation, refinements in surgical techniques and changes in postoperative management have all contributed. Any major technical modification of the Fontan operation must be evaluated in light of the improved outcomes observed after nonfenestrated Fontan operations in the recent cohort.
